stockrow
Friday 6 November 2026
Export ACON’s income statement to Excel — free account
Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024.
- Revenue
- +78.5%
- EPS
- +67.9%
- Free cash flow
- −74.2%
Quarter to September 2026, against a year earlier
1.66
0.10
+6.41%
Follow ACON
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Sep ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | +18.8% | 0 | 0 | 5 | +291.0% | |
| Gross margin, % | — | — | — | (576.58) | (36.14) | (14.76) | (8.11) | (0.40) | (85.12) | 8.98 | 29.12 | +585.6 pt | ||||||
| EBT | — | — | — | (4) | (5) | (5) | (7) | (5) | (7) | (7) | (10) | +10.3% | ||||||
| EBT margin, % | — | — | — | (14,941.64) | (9,517.86) | (8,209.45) | (11,702.98) | (6,513.79) | (15,301.75) | (9,555.61) | (10,262.89) | +5,386.0 pt | ||||||
| Net income | — | 0 | — | (4) | (5) | (5) | (7) | (5) | (7) | (7) | (10) | n/m | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | 8,674.06 | 7,781.79 | 9,635.36 | 1,431.66 | 1,216.13 | 50.78 | 0.14 | 0.04 | (84.1%) | |||||
| Earnings | — | — | — | (1,562,866.36) | (876,758.31) | (951,695.25) | (177,395.63) | (79,459.45) | (7,480.00) | (13.61) | (5.94) | (85.7%) | ||||||
| Cash flow | — | — | — | (1,345,027.73) | (286,631.94) | (383,480.87) | (117,308.39) | (58,820.97) | (5,857.33) | (13.47) | (3.22) | (85.3%) | ||||||
| Capex | — | — | — | 0.00 | (28,602.47) | (16,298.62) | (4,927.85) | (1,927.42) | (357.67) | (0.38) | (0.07) | n/m | ||||||
| Free cash flow | — | — | — | (1,345,027.73) | (315,234.41) | (399,779.49) | (122,236.23) | (60,748.39) | (6,215.00) | (13.85) | (3.29) | (85.3%) | ||||||
| Book value | — | — | — | (548,787.57) | (1,131,890.96) | (915,486.88) | 52,762.82 | (11,741.94) | 1,077.89 | 24.13 | 5.33 | n/m | ||||||
| Shares, m | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | +645.4% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.0 | |||||
| P/S | — | — | — | 42.77 | 42.77 | 42.77 | 74.30 | 29.84 | 34.68 | 32.33 | 43.71 | 42.8 | ||||||
| P/B | — | — | — | 0.00 | 0.00 | 0.00 | 2.02 | 0.00 | 1.63 | 0.19 | 0.29 | 0.5 | ||||||
| EV/Sales | — | — | — | 46.01 | 46.01 | 46.01 | 53.84 | 19.46 | 29.94 | (123.47) | (98.02) | 16.8 | ||||||
| EV/FCF | — | — | — | (1.03) | (1.03) | (1.03) | (0.63) | (0.39) | (0.24) | 1.27 | 1.05 | (0.4) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | (4) | (2) | (2) | (5) | (4) | (5) | (7) | (9) | +9.4% | |||||
| Capex | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (4.4%) | ||||||
| Free cash flow | — | — | — | (4) | (2) | (3) | (5) | (4) | (6) | (7) | (9) | +9.9% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | (3) | (8) | (7) | 1 | (2) | 0 | 12 | 14 | n/m | |||||
| Net debt | — | — | — | 0 | 0 | 0 | (1) | (1) | 0 | (12) | (14) | n/m | ||||||
| Shareholders’ equity | — | — | — | (2) | (7) | (6) | 2 | (1) | 1 | 13 | 15 | n/m | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | (677.67) | (403.12) | (374.43) | (311.57) | (182.77) | (307.75) | (91.67) | (69.66) | +586.0 pt | |||||
| ROIC | — | — | — | 0.00 | 0.00 | 0.00 | (467.71) | 0.00 | (680.42) | (554.92) | (1,120.88) | (554.9) pt | ||||||
| ROE | — | — | — | 0.00 | 124.90 | 59.81 | 141.13 | (655.73) | (5,826.19) | (104.89) | (74.07) | (104.9) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | 6 | 7 | 6 | 6 | 11 | — | +16.4% | |||||
| Revenue/emp, $m | — | — | — | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | — | n/m | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 5 Nov 2026
Aclarion, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| BFRG Bullfrog AI Holdings Inc. | $9.1M | — (loss-making) | — (loss-making) | +2,054.00% (above 0%: growing) | n/m | −5.67% (below 0%: shrinking) | 49.63% | (658.82%) | Compare |
| HLTHQ Cue Health Inc. | $6.9M | — (loss-making) | — (loss-making) | −87.19% (below 0%: shrinking) | n/m | +50.55% (above 0%: growing) | (90.14%) | (792.13%) | Compare |
| ACON Aclarion, Inc. | $4.5M | — (loss-making) | — (loss-making) | +78.48% (above 0%: growing) | n/m | −74.22% (below 0%: shrinking) | 43.86% | (8,164.70%) | |
| MGRX Mangoceuticals, Inc. | $4.3M | — (loss-making) | — | −59.07% (below 0%: shrinking) | n/m | +79.27% (above 0%: growing) | 64.24% | (1,501.45%) | Compare |
| ZCMD Zhongchao Inc. | $4.3M | — (loss-making) | — | +20.44% (above 0%: growing) | −550.00% (below 0%: shrinking) | +191.85% (above 0%: growing) | 41.67% | 0.00% | Compare |
| HCTI Healthcare Triangle, Inc. | $3.2M | 0.0× | — (loss-making) | +158.38% (above 0%: growing) | n/m | +67.48% (above 0%: growing) | 22.48% | (44.28%) | Compare |
| VSEE VSee Health, Inc. | $2.8M | — (loss-making) | — (loss-making) | −53.93% (below 0%: shrinking) | n/m | −257.62% (below 0%: shrinking) | 13.20% | (172.69%) | Compare |
| WORX SCWorx Corp. | $2.0M | — (loss-making) | — (loss-making) | +3.43% (above 0%: growing) | n/m | +87.99% (above 0%: growing) | 46.80% | (17.14%) | Compare |
| MSPR MSP Recovery, Inc. | $1.5M | — (loss-making) | — | −94.60% (below 0%: shrinking) | n/m | +60.88% (above 0%: growing) | (26.77%) | (62,501.52%) | Compare |
| Median of peers | $3.7M | — | — | −25.25% | — | +64.18% | 32.08% | (415.75%) |
Pay and ownership Proxy statement filed 27 April 2026
Ownership
Directors and executive officers, together
less than 1%
SEG Opportunity Fund, LLC
9.90%
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement